FOR US RESIDENTS ONLY
NOW APPROVED For the treatment of Dystrophic Epidermolysis Bullosa (DEB) in patients 6 months and older

Starting VYJUVEK

TREATMENT WITH VYJUVEK

VYJUVEK is applied topically once weekly to promote wound healing

  • Only a healthcare professional can prescribe and apply VYJUVEK gel. There are special storage and preparation requirements with VYJUVEK
  • VYJUVEK can be administered by a healthcare professional at a healthcare professional setting (for example, a clinic) or home setting, depending on your doctor’s instructions, your insurance plan coverage, and your preference
  • VYJUVEK can be administered in the course of routine bandage changes at home
  • To begin administration, the wound must be unwrapped
  • VYJUVEK gel is then applied in small droplets that are evenly spaced (1 cm by 1 cm apart) on the selected wound to form a thin film after a water-resistant dressing is applied. Other wounds are then treated until the maximum weekly dose is reached. Wounds are covered by a water-resistant dressing. Standard dressings are then applied on top
  • Routine dressing changes can resume after approximately 24 hours
    • Avoid touching the treated wounds and dressings for the first 24 hours after application. In case accidental contact happens, flush the affected area with clean water for at least 15 minutes
    • Wash hands and wear protective gloves when changing wound dressings. Disinfect bandages from first dressing change and dispose of disinfected bandages in a separate sealed plastic bag in household waste. Dispose of subsequent used dressings in a sealed plastic bag in household waste
VYJUVEK™ is applied topically once weekly to promote wound healing

VYJUVEK has a maximum weekly dose dependent upon patient age

Maximum weekly dose of VYJUVEK™ dependent upon patient age Maximum weekly dose of VYJUVEK™ dependent upon patient age

*For illustrative purposes only. The total surface area covered may vary. Your healthcare provider will follow the 1cm by 1cm application process based on the full Prescribing Information

VYJUVEK has a maximum weekly dose dependent upon patient age

Creating a VYJUVEK treatment plan

Because of the maximum weekly dose, it may not be possible to apply VYJUVEK gel to all wounds during your appointment—you and your doctor can work together to create a prioritized wound treatment plan.

Creating a VYJUVEK™ treatment plan

It is important to continue weekly treatment of each treated wound(s) until it is fully healed. Once completely healed, other wound(s) can be treated with VYJUVEK.

Once you and your doctor have determined VYJUVEK is right for you, the next
step is to download and fill out this form with your doctor.

 Download the Enrollment Form
Find More Support and Resources
INDICATION AND USAGE

VYJUVEK is a topical gel used to treat wounds in patients 6 months and older with dystrophic epidermolysis bullosa (DEB).

IMPORTANT SAFETY INFORMATION

VYJUVEK gel must be applied by a healthcare provider.

After treatment, patients and caregivers should be careful not to touch treated wounds and dressings for 24 hours. If accidentally exposed to the VYJUVEK gel, clean the affected area.

Wash hands and wear protective gloves when changing wound dressings. Disinfect bandages from the first dressing change with a virucidal agent, and dispose of the disinfected bandages in a separate sealed plastic bag in household waste. Dispose of the subsequent used dressings in a sealed plastic bag in household waste.

Patients should avoid touching or scratching wound sites or wound dressings.

The most common adverse reactions (>5%) were itching, chills, redness, rash, cough, and runny nose. These are not all the possible side effects with VYJUVEK. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or to the Sponsor at 1-844-557-9782.

  • Please see Important Safety Information above and click here for full Prescribing Information.
IMPORTANT SAFETY INFORMATION
INDICATION AND USAGE

VYJUVEK is a topical gel used to treat wounds in patients 6 months and older with dystrophic epidermolysis bullosa (DEB).

IMPORTANT SAFETY INFORMATION

VYJUVEK gel must be applied by a healthcare provider.

After treatment, patients and caregivers should be careful not to touch treated wounds and dressings for 24 hours. If accidentally exposed to the VYJUVEK gel, clean the affected area.

Wash hands and wear protective gloves when changing wound dressings. Disinfect bandages from the first dressing change with a virucidal agent, and dispose of the disinfected bandages in a separate sealed plastic bag in household waste. Dispose of the subsequent used dressings in a sealed plastic bag in household waste.

Patients should avoid touching or scratching wound sites or wound dressings.

The most common adverse reactions (>5%) were itching, chills, redness, rash, cough, and runny nose. These are not all the possible side effects with VYJUVEK. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or to the Sponsor at 1-844-557-9782.

  • Please see Important Safety Information above and click here for full Prescribing Information.